We are not a staffing agency and not a generalist contractor. Vascular access is the entire business — which is why hospitals trust us with it.
Power PICC and Triple Lumen Power PICC placement for infusion therapy, long-course antibiotics, chemotherapy, TPN, and frequent blood draws. Power-injectable for contrast studies.
Midline placement for therapies of intermediate duration — preserving peripheral vessels and avoiding unnecessary central access when a midline is the right call.
Ultrasound-guided placement for the patients your floor nurses dread sticking — fragile vessels, edema, history of multiple failed attempts. Published literature puts peripheral IV failure at 35–50% even in skilled hands; this is where a specialist changes the math.
Device selection follows appropriateness frameworks (MAGIC, Ann Intern Med): therapies under roughly five days that are peripherally compatible don't need a PICC, and we'll say so. Line-necessity discipline protects patients, preserves vessels, and keeps your CLABSI denominators honest.
No wound care, no infusion administration, no general staffing services, no scope creep. Declining adjacent work is part of why the placement record looks the way it does. One specialty, all day, every day.
A provider orders the line; our inserter is dispatched to the bedside. After-hours, weekend, and holiday requests are part of the service, not an exception to it.
Ultrasound-guided placement under maximal sterile barrier precautions, using supplies we bring. The patient never leaves the unit.
Tip position is confirmed by X-ray before the line is released for use, and the placement is documented in full. The line is ready when we say it's ready.
Hospitals already outsource imaging, dialysis, and emergency staffing. Vascular access is the same logic — applied to a procedure where specialist volume visibly drives outcomes.
Average cost to replace one departing staff RN, per NSI's national retention report — before counting the ~83 days it takes to recruit an experienced replacement. A vascular access FTE is a recurring bet on that market.
PICC insertions performed in U.S. acute care every year — and demand keeps growing with outpatient antibiotic therapy, oncology, and an aging population. The need is structural, not cyclical.
Published average cost of a single central line–associated bloodstream infection (AHRQ-cited research) — and CLABSI performance feeds the CMS penalty programs. Insertion discipline is financial discipline.
We share full pricing and reference terms directly with facility leadership.
Request details